A prospective observational study to investigate real-world IMmunogenicity of theraPeutic Antibodies and to identify faCTors responsible for the interindividual variability

Not Applicable

Recruiting

• Conditions: IBD, Psoriasis, Palmoplantar pustulosis, Malignant tumors (Melanoma etc.), RA, Autoimmune diseases; D015212 , D011565, D008545, D001172, D001327, D009369

• Registration Number: JPRN-jRCT1011220023
• Lead Sponsor: Fukudo Masahide

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-10-29
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

Subjects whose medical care and prognostic information can be obtained from medical records

Exclusion Criteria

Subjects presenting with any of the following will be excluded from the study:
1. Subjects who requested non-participation in this study based on a published opt-out document.
2. Subjects who are participating in or interested in participating in other clinical trials during the study period.
3. Subjects who are judged as not suitable for participating in this study by treating physician.

Study & Design

• Study Type: Observational
• Study Design: Not specified